Covert dissemination of pLVPK-like virulence plasmid in ST29-K54 Klebsiella pneumoniae: emergence of low virulence phenotype strains

Front Cell Infect Microbiol. 2023 Sep 27:13:1194133. doi: 10.3389/fcimb.2023.1194133. eCollection 2023.

Abstract

This study aimed to explore the epidemic, clinical characteristics, and molecular and virulence attributes of Klebsiella pneumoniae serotype K54 (K54-Kp). A retrospective study was conducted on 328 strains of Klebsiella pneumoniae screened in a Chinese hospital from January 2016 to December 2019. The virulence genes and antibiotic resistance genes (ARGs) were detected by PCR, and a drug sensitivity test was adopted to detect drug resistance. Multilocus sequence typing (MLST) and PFGE were performed to determine the clonal correlation between isolates. Biofilm formation assay, serum complement-mediated killing, and Galleria mellonella infection were used to characterize the virulence potential. Our results showed that thirty strains of K54-Kp were screened from 328 strains of bacteria, with an annual detection rate of 2.29%. K54-Kp had a high resistance rate to antibiotics commonly used in the clinic, and patients with hepatobiliary diseases were prone to K54-Kp infection. MLST typing showed 10 sequence typing, mainly ST29 (11/30), which concentrated in the B2 cluster. K54-Kp primarily carried virulence genes of aerobactin, silS, allS, wcaG, wabG, and mrkD, among which the terW gene was closely related to ST29 (p<0.05). The strains infected by the bloodstream had strong biofilm formation ability (p<0.05). Most strains were sensitive to serum. Still, the virulence of pLVPK-like virulence plasmid in ST29-K54 Klebsiella pneumoniae was lower than that of ST11 type and NTUH-K2044 in the Galleria mellonella model. Therefore, these findings supply a foundation to roundly comprehend K54-Kp, and clinicians should strengthen supervision and attention.

Keywords: ST29-k54; capsular serotype; clinical characteristics; klebsiella pneumoniae; virulence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Klebsiella Infections* / microbiology
  • Klebsiella pneumoniae
  • Moths*
  • Multilocus Sequence Typing
  • Phenotype
  • Plasmids / genetics
  • Retrospective Studies
  • Virulence / genetics

Substances

  • Anti-Bacterial Agents

Grants and funding

Financial support was provided by the National Natural Science Foundation of China (82102411, 82260403), 2020 Clinical Research and Cultivation project of the First Affiliated Hospital(YFYLCYJPY202201). Jiangxi Provincial Health Commission science and technology plan project (202210370). Jiangxi Province applied research and cultivation program (2018BBG78021).